Quantitative Methods to Determine Efficacy of Treatment in Achalasia

Overview

Journal Gastrointest Endosc Clin N Am

Specialties Gastroenterology
Pharmacology
Radiology

Date 2001 Apr 25

PMID 11319070

Citations 6

Authors

M F Vaezi

Affiliations

Soon will be listed here.

Abstract

Determining success after achalasia therapy is an important aspect of treating this disease. Esophageal manometry, scintigraphy, and barium esophagram are the most commonly employed techniques. Recent data suggest that barium esophagram may be most practical and informative compared to manometry and scintigraphy in predicting treatment success in achalasia patients after therapy.

Citing Articles

Esophagogastric Junction Distensibility on Functional Lumen Imaging Probe Topography Predicts Treatment Response in Achalasia-Anatomy Matters!.

Jain A, Carlson D, Triggs J, Tye M, Kou W, Campagna R Am J Gastroenterol. 2019; 114(9):1455-1463.

PMID: 30741739 PMC: 6682473. DOI: 10.14309/ajg.0000000000000137.

High-Resolution Impedance Manometry Metrics of the Esophagogastric Junction for the Assessment of Treatment Response in Achalasia.

Carlson D, Lin Z, Kahrilas P, Sternbach J, Hungness E, Soper N Am J Gastroenterol. 2016; 111(12):1702-1710.

PMID: 27698386 PMC: 5224522. DOI: 10.1038/ajg.2016.442.

Idiopathic (primary) achalasia: a review.

Patel D, Kim H, Zifodya J, Vaezi M Orphanet J Rare Dis. 2015; 10:89.

PMID: 26198208 PMC: 4509143. DOI: 10.1186/s13023-015-0302-1.

Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia.

Jung H, Lee J, Lee T, Kim J, Hong S, Kim J Korean J Intern Med. 2014; 29(6):738-45.

PMID: 25378972 PMC: 4219963. DOI: 10.3904/kjim.2014.29.6.738.

Idiopathic (primary) achalasia.

Farrokhi F, Vaezi M Orphanet J Rare Dis. 2007; 2:38.

PMID: 17894899 PMC: 2040141. DOI: 10.1186/1750-1172-2-38.